On October 6-8 Hannover Germany will be host to Biotechnica 2009. The three day event is a showcase for exhibitors, professionals and speakers that highlight the latest discoveries, innovations and products in the biotechnical world.
One of the top themes this year is bioinformatics or Bio IT. Pharmaceutical and medical research has been challenged every year with the enormous growth of biological data that must be analyzed, disseminated and safeguarded on such a large scale. Procedures will be presented that are aimed at making lab work easier, help simplify data analysis and incorporate specialized databases.
The Cambridge Healthtech Institute (CHI) has organized Bio-IT World Europe. This is the first time that this leader in biomedical conferences in the United States has brought their exhibition to Europe. There will be more than 70 lecture groups that will be divided into four categories: IT hardware and IT software for the life sciences; data integration, knowledge management, and bioinformatics for genomics.
The pharmaceutical segment will focus on biologicals especially monoclonal antibodies and recombinant proteins which will be exhibited as Protein Engineering. This is in conjunction with the first Protein Engineering Summit Europe which was also organized by Cambridge
For the first time at Biotechnica modern techniques will be addressed regarding bone regeneration. International scientists will come together to explore and share different aspects of the regeneration of bone, tendons, ligaments and cartilage.
Opening ceremonies for Biotechnica will actually begin on October 5th by Dr. Phillip Rosler, Lower Saxony’s Minister for Economic Affairs, and Dr. Stefan Marcinowski, president of the German Biotech Industry Association. Opening ceremony speakers also include Kary Mullis, an American who was winner of the Nobel Prize for Chemistry in 1993 and the inventor of the Polymerase Chain Reaction (PCR). The event culminates in the Biotechnica Award which carries a prize valued at 100,000 euros.
The Biotechnica event, besides providing a forum for breakthrough medical information, partners joint venture partners with companies or organizations that could use funding to continue their research and clinical trials. A forum aptly entitled Science to Market is organized by the European Association of Pharma Biotechnology (EAPB). This is where the biopharmaceutical industry and European research facilities can present and promote their scientific innovations.
The Biotechnology Project Forum is organized by the Federal Ministry of Education and Research and shows the biotech programs that were developed with government funding. Other gatherings include Biomanufacturing, Life Science Spotlight and Bio-Based Economy.
A one day Bio@Venture Conference will be held in light of effect that the global financial crisis has had on financing important research and development programs. The purpose is to put companies in contact with investors who may be able to provide needed funding for future biomedical projects regarding development and implementation of much needed medical technology and devices.
Biotechnica also serves as an important networking facilitation between skilled personnel and companies that are looking for qualified employees. Biotechnica works in conjunction with jobvector in helping place qualified personnel with the right companies.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.